beta-thujaplicin has been researched along with Colonic Neoplasms in 2 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
Colonic Neoplasms: Tumors or cancer of the COLON.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, YS | 1 |
Choi, KM | 1 |
Kim, W | 1 |
Jeon, YS | 1 |
Lee, YM | 1 |
Hong, JT | 1 |
Yun, YP | 1 |
Yoo, HS | 1 |
Seo, JS | 1 |
Choi, YH | 1 |
Moon, JW | 1 |
Kim, HS | 1 |
Park, SH | 1 |
2 other studies available for beta-thujaplicin and Colonic Neoplasms
Article | Year |
---|---|
Hinokitiol inhibits cell growth through induction of S-phase arrest and apoptosis in human colon cancer cells and suppresses tumor growth in a mouse xenograft experiment.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Colonic Neoplasms; Genes, bcl-2; HCT116 Cells; Humans; I | 2013 |
Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
Topics: 5-Methylcytosine; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Colonic Neo | 2017 |